Search Results 491-500 of 38043 for Two-phase
The purpose of this study is toassess efficacy of neoadjuvant cemiplimab and fianlimab in patients with resectable/early-stage NSCLC with PD-L1 1-49%, as ...
About this study. This is a global, multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study ...
Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
The study is divided into two parts: single agent FT-2102 followed by combination therapy. ... Phase 2 investigation of clinical activity in up to 4 cohorts.
This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune® (Tumor Treating Fields at 200 kHz) together with maintenance ...
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential ... The aim of this research is to look at two conditions, Essential Thrombocythemia (ET) ...
This is a single-arm, two-stage, phase II trial to assess the efficacy of ... Phase 2 investigation of clinical activity in up to 4 cohorts. During the ...
Phase 2: Intensive Outpatient Program. Participants engage in mindfulness ... Based on need and collaborative understanding of presenting concerns, patients can ...
The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be administered ...
... Phase 2 dose (RP2D). BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.